Literature DB >> 30947869

The Liver and Celiac Disease.

Alberto Rubio-Tapia1, Joseph A Murray2.   

Abstract

Celiac disease is a multisystem disorder. Celiac hepatitis characterized by gluten-responsive mild elevation of transaminases is the more common liver manifestation of celiac disease. Celiac disease may also be associated or coexist with other chronic liver disorders. Shared genetic risk and increased intestinal permeability have been suggested to be the most relevant events in the pathogenesis of liver injury in celiac disease. The aim of this article is to review the full spectrum of liver disorders in patients with celiac disease.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alanine aminotransferase; Cirrhosis; Hepatitis

Mesh：

Year:  2019        PMID： 30947869      PMCID： PMC6588186          DOI： 10.1016/j.cld.2018.12.001

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN： 1089-3261            Impact factor:   6.126


  58 in total

1.  Celiac disease during interferon treatment.

Authors:  M T Bardella; R Marino; P L Meroni
Journal:  Ann Intern Med       Date:  1999-07-20       Impact factor: 25.391

2.  Interferon and ribavirin treatment for chronic hepatitis C may activate celiac disease.

Authors:  L E Adinolfi; E Durante Mangoni; A Andreana
Journal:  Am J Gastroenterol       Date:  2001-02       Impact factor: 10.864

3.  Adult celiac disease: US signs.

Authors:  T Rettenbacher; A Hollerweger; P Macheiner; S Huber; N Gritzmann
Journal:  Radiology       Date:  1999-05       Impact factor: 11.105

4.  The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis.

Authors:  K M Boberg; A Spurkland; G Rocca; T Egeland; S Saarinen; S Mitchell; U Broomé; R Chapman; O Olerup; A Pares; F Rosina; E Schrumpf
Journal:  Scand J Gastroenterol       Date:  2001-08       Impact factor: 2.423

5.  Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure.

Authors:  Katri Kaukinen; Leena Halme; Pekka Collin; Martti Färkkilä; Markku Mäki; Paula Vehmanen; Jukka Partanen; Krister Höckerstedt
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

6.  Risk of primary biliary liver cirrhosis in patients with coeliac disease: Danish and Swedish cohort data.

Authors:  H T Sorensen; A M Thulstrup; P Blomqvist; B Nørgaard; K Fonager; A Ekbom
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

7.  Celiac sprue: another autoimmune syndrome associated with hepatitis C.

Authors:  K D Fine; F Ogunji; Y Saloum; S Beharry; J Crippin; J Weinstein
Journal:  Am J Gastroenterol       Date:  2001-01       Impact factor: 10.864

8.  Chronic unexplained hypertransaminasemia may be caused by occult celiac disease.

Authors:  M T Bardella; M Vecchi; D Conte; E Del Ninno; M Fraquelli; S Pacchetti; E Minola; M Landoni; B M Cesana; R De Franchis
Journal:  Hepatology       Date:  1999-03       Impact factor: 17.425

9.  Prevalence and clinical importance of hypertransaminasaemia in coeliac disease.

Authors:  G Novacek; W Miehsler; F Wrba; P Ferenci; E Penner; H Vogelsang
Journal:  Eur J Gastroenterol Hepatol       Date:  1999-03       Impact factor: 2.566

10.  Prevalence of IgA antibodies to endomysium and tissue transglutaminase in primary biliary cirrhosis.

Authors:  H R Gillett; K Cauch-Dudek; E Jenny; E J Heathcote; H J Freeman
Journal:  Can J Gastroenterol       Date:  2000-09       Impact factor: 3.522
View more
  6 in total

Review 1.  The global burden of coeliac disease: opportunities and challenges.

Authors:  Govind K Makharia; Prashant Singh; Carlo Catassi; David S Sanders; Daniel Leffler; Raja Affendi Raja Ali; Julio C Bai
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-01-03       Impact factor: 46.802

2.  Bi-directional Relationship Between Celiac Disease and Liver Chemistries: A Systematic Review and Meta-Analysis.

Authors:  Manik Aggarwal; Rajat Garg; Prabhat Kumar; Christina C Lindenmeyer; Jamile Wakim-Fleming; Claire Jansson-Knodell; Alberto Rubio-Tapia
Journal:  Dig Dis Sci       Date:  2022-08-24       Impact factor: 3.487

3.  Current guidelines for the management of celiac disease: A systematic review with comparative analysis.

Authors:  Alberto Raiteri; Alessandro Granito; Alice Giamperoli; Teresa Catenaro; Giulia Negrini; Francesco Tovoli
Journal:  World J Gastroenterol       Date:  2022-01-07       Impact factor: 5.742

4.  Microbiome and metabolome profiles of high screen time in a cohort of healthy college students.

Authors:  Paniz Jasbi; Alex E Mohr; Xiaojian Shi; Tara Mahmood; Qiyun Zhu; Meg Bruening; Haiwei Gu; Corrie Whisner
Journal:  Sci Rep       Date:  2022-03-02       Impact factor: 4.379

5.  Hepatobiliary phenotype of individuals with chronic intestinal disorders.

Authors:  Jessica Voss; Carolin V Schneider; Moritz Kleinjans; Tony Bruns; Christian Trautwein; Pavel Strnad
Journal:  Sci Rep       Date:  2021-10-07       Impact factor: 4.379

Review 6.  Review article: Follow-up of coeliac disease.

Authors:  J A Tye-Din
Journal:  Aliment Pharmacol Ther       Date:  2022-07       Impact factor: 9.524
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.